Literature DB >> 7827955

Nature and the multiple functions of the 67-kD elastin-/laminin binding protein.

A Hinek1.   

Abstract

Numerous cell types, including fibroblasts, vascular smooth muscle cells, chondroblasts, monocytes, neutrophils, and several tumor cells express the 67-kD galactolectin, homologous to the alternatively spliced variant of beta-galactosidase. The 67-kD protein resides on the cell surfaces and is capable of interacting with elastin, laminin and collagen type IV. This peripheral membrane protein binds its matrix ligands but only in the absence of galactosugars, whereas binding of galactosugar-containing moieties to its lectin site changes its molecular folding which causes discharge of the ligand and release of the receptor from the cell surface. This review will address the functional significance of the single receptor that interacts with multiple matrix proteins and can be shed from cell surfaces by galactosugars. I will emphasize the role of the 67-kD protein in divergent cellular processes, such as cell-matrix attachment, matrix assembly, cellular chemotaxis, and active migration through the vascular walls.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827955     DOI: 10.3109/15419069409004436

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  27 in total

1.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Authors:  A Hinek; S E Wilson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  The cellular basis of metastasis.

Authors:  P Ruiz; U Günthert
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia.

Authors:  G Tronchin; K Esnault; G Renier; R Filmon; D Chabasse; J P Bouchara
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 4.  Vascular wall extracellular matrix proteins and vascular diseases.

Authors:  Junyan Xu; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-07-18

5.  Sialic acid-dependent recognition of laminin and fibrinogen by Aspergillus fumigatus conidia.

Authors:  J P Bouchara; M Sanchez; A Chevailler; A Marot-Leblond; J C Lissitzky; G Tronchin; D Chabasse
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 6.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

7.  Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity.

Authors:  Chi-Fan Yang; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2010-09-30       Impact factor: 8.410

8.  Fibulin-4 regulates expression of the tropoelastin gene and consequent elastic-fibre formation by human fibroblasts.

Authors:  Qiuyun Chen; Teng Zhang; Joseph F Roshetsky; Zhufeng Ouyang; Jeroen Essers; Chun Fan; Qing Wang; Aleksander Hinek; Edward F Plow; Paul E Dicorleto
Journal:  Biochem J       Date:  2009-09-14       Impact factor: 3.857

9.  Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells.

Authors:  Caroline Kinnear; Wing Y Chang; Shahryar Khattak; Aleksander Hinek; Tadeo Thompson; Deivid de Carvalho Rodrigues; Karen Kennedy; Naila Mahmut; Peter Pasceri; William L Stanford; James Ellis; Seema Mital
Journal:  Stem Cells Transl Med       Date:  2012-12-21       Impact factor: 6.940

10.  Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line.

Authors:  B Brassart; A Randoux; W Hornebeck; H Emonard
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.